Boston Scientific 10Q 2012 Q1 Quarterly report | BSX Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Good

New words: abroad, acute, adjacent, advisory, Affordability, Affordable, ALTRUA, antitrust, area, attempt, attempting, BackStop, bore, brain, burden, Cameron, Charger, circumvented, clearance, computer, conceded, consortium, constitutionality, conversion, coordinated, costly, customary, DBS, deep, deterioration, diminished, doubled, Eurodollar, exciting, gel, Gladiator, headquartered, HeartSpan, increasingly, inducement, inefficiency, Infinion, irrespective, malfunction, mandate, marketplace, meaningfully, metal, migration, misuse, mitigate, Moreci, multicurrency, national, passed, payable, payer, pertaining, pilot, Portugal, precautionary, prejudgment, premarket, pretrial, prevent, produce, proposition, PTA, rely, remeasured, remote, REPRISE, reputation, rollout, sector, side, slight, slowdown, Smoothwave, Spain, steerable, Stephen, sum, TAVR, thereof, tiered, Trademark, transcatheter, Transformation, Transhepatic, transvaginal, unauthorized, unclear, understood, unemployment, unknown, unsuccessful, unwanted, VANTAGE, versatile, viability, vulnerable, West, Western, willfully

Removed: abdominal, accept, acting, administration, Agent, agreed, allegedly, allocate, amend, ANCURE, answer, answered, Apex, appealed, asserting, assume, bifurcate, book, broader, building, California, capacity, caption, centralization, chain, Circuit, commercialized, communication, concealed, concealing, concealment, concluding, confidential, conformability, consent, CONTAK, contest, contingency, continuum, Cosmetic, County, customer, defer, demand, demanding, demonstration, denying, deployment, determination, died, Director, discharge, disgorgement, dismissal, dismissing, documenting, Dr, duty, eligibility, elimination, Endograft, Engineering, equitable, Escape, escrowed, EVM, exclusively, expanded, expiration, expired, failing, Falotico, fiduciary, finalization, finalized, flaw, Florida, Food, forecasting, formally, Fry, Gap, guilty, Hampshire, impaired, injunction, introduce, introduced, issuable, labeling, Labor, leave, light, lived, long, manufactured, marker, marketed, Markman, Math, mechanical, Medinol, Medtronic, merit, MHLW, mid, Middlesex, milestone, Ministry, Mirowski, misdemeanor, Mississippi, Multidistrict, multistate, natural, NC, negligence, NIR, notified, notional, objective, occurred, older, optimizing, ordered, paragraph, participating, pattern, PAVR, permanent, perpetual, petition, plea, plead, pled, power, practicing, prepaid, prepay, prepayment, preside, principle, probation, probationary, promissory, proper, prospectively, punitive, pursued, putative, qualitative, Quantum, radiopacity, Ranger, recall, receiving, refile, refund, refusal, reinvested, reject, relation, reliant, remanding, removal, removed, rendered, RENEWAL, reoperation, repay, repeated, residual, resolving, responded, response, retire, Robert, run, Sachdeva, scheduled, sentencing, separated, separately, settled, settling, Shankar, ship, short, situated, slightly, Sox, specialty, spending, Srinivasan, STEM, strict, sublicensed, subsidiary, suffered, Supplementary, supposed, surgery, suspend, syndrome, Tennessee, therapeutic, transitional, true, undelivered, understand, unenforceability, unenforceable, unrestricted, unsecured, upheld, validity, VENTAK, verifiable, violation, voluntarily, Welfare, worked, Wright, XIENCE



	(1)	the Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and
	(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Boston Scientific Corporation.




By:	/s/ William H. Kucheman
	William H. Kucheman
	Chief Executive Officer

	May 3, 2012

Boston Scientific (BSX) 10-Q2012 Q1 Quarterly report

Content analysis